Clinical Trials Browser

Withdrawn × Mesothelioma, Malignant × pembrolizumab × Clear all

NCT04201145 2020-11-17

Pembrolizumab + Defactinib In Pleural Mesothelioma

Phase 1 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant